Registration Statement

Amphastar Pharmaceuticals, Inc. Filed 2018-11-09 Acc 0001558370-18-009176

Documents 1

2021-11-09 S-3 Registration Statement
2018-11-09 S-3 Registration Statement
2018-11-09 10-Q Quarterly Report
2018-11-09 4 President and General Counsel sold 52,296 shares at an average $20.77 ($1,086,420)
2018-11-08 8-K Other events
2018-11-08 8-K Results of operations
2015-07-02 S-3 Registration Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading s-3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…